Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cirtran (CIRX) EBIT (2017 - 2025)

Historic EBIT for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to -$166504.0.

  • Cirtran's EBIT rose 2507.41% to -$166504.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$590834.0, marking a year-over-year decrease of 35028.27%. This contributed to the annual value of -$550739.0 for FY2024, which is 359202.25% down from last year.
  • According to the latest figures from Q3 2025, Cirtran's EBIT is -$166504.0, which was up 2507.41% from -$193258.0 recorded in Q2 2025.
  • Over the past 5 years, Cirtran's EBIT peaked at $231726.0 during Q4 2023, and registered a low of -$242616.0 during Q4 2022.
  • Its 5-year average for EBIT is -$89791.7, with a median of -$99121.0 in 2023.
  • In the last 5 years, Cirtran's EBIT skyrocketed by 19551.14% in 2023 and then plummeted by 14924429.53% in 2024.
  • Quarter analysis of 5 years shows Cirtran's EBIT stood at -$132025.0 in 2021, then plummeted by 83.77% to -$242616.0 in 2022, then skyrocketed by 195.51% to $231726.0 in 2023, then plummeted by 181.04% to -$187799.0 in 2024, then grew by 11.34% to -$166504.0 in 2025.
  • Its EBIT stands at -$166504.0 for Q3 2025, versus -$193258.0 for Q2 2025 and -$43273.0 for Q1 2025.